Article
Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment.
BMC cancer - 23 Feb 2010
Tokalov Sergey V, Abolmaali Nasreddin D
Abstract excerpt
BACKGROUND: Mutations within the tumor suppressor TP53 gene are one of the most common genetic alterations present at high frequency in human tumors and have been shown to be associated with resistance to radio-chemotherapy. The lack of the wild type TP53 gene in cancer cells could be exploited f...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
